These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35579794)

  • 21. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases.
    Korkmaz H; Asıl M; Temel T; Öztürk B; Kebapçılar L
    Turk J Med Sci; 2021 Oct; 51(5):2403-2412. PubMed ID: 33984894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease.
    Yordanova M; Gerova D; Atanassova A; Galunska B
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia.
    Neubauer K; Bednarz-Misa I; Walecka-Zacharska E; Wierzbicki J; Agrawal A; Gamian A; Krzystek-Korpacka M
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
    Kader HA; Tchernev VT; Satyaraj E; Lejnine S; Kotler G; Kingsmore SF; Patel DD
    Am J Gastroenterol; 2005 Feb; 100(2):414-23. PubMed ID: 15667502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Neutrophil/Lymphocyte Ratio Assess Inflammatory Bowel Disease Activity and Severity in Children?
    Metwally RH
    Turk J Gastroenterol; 2022 Dec; 33(12):1058-1061. PubMed ID: 36098358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Vitamin D with Inflammatory Bowel Disease Activity in Pediatric Patients.
    Kim S; Kang Y; Park S; Koh H; Kim S
    J Korean Med Sci; 2019 Aug; 34(32):e204. PubMed ID: 31432649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil-lymphocyte ratios in blood to distinguish children with asthma exacerbation from healthy subjects.
    Pan R; Ren Y; Li Q; Zhu X; Zhang J; Cui Y; Yin H
    Int J Immunopathol Pharmacol; 2023; 37():3946320221149849. PubMed ID: 36598755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
    Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
    Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
    Borkowska A; Liberek A; Łuczak G; Jankowska A; Plata-Nazar K; Korzon M; Kamińska B
    Acta Biochim Pol; 2015; 62(3):541-5. PubMed ID: 26339799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in the investigation of pediatric inflammatory bowel disease.
    Lemberg DA; Issenman RM; Cawdron R; Green T; Mernagh J; Skehan SJ; Nahmias C; Jacobson K
    Inflamm Bowel Dis; 2005 Aug; 11(8):733-8. PubMed ID: 16043988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease.
    Al-Rshaidat MMD; Al-Sharif S; Refaei AA; Shewaikani N; Alsayed AR; Rayyan YM
    Pharm Pract (Granada); 2023; 21(1):2755. PubMed ID: 37090461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.
    Ziade F; Rungoe C; Kallemose T; Paerregaard A; Wewer AV; Jakobsen C
    Dig Dis; 2019; 37(2):140-146. PubMed ID: 30423580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    Shimizu H; Ebana R; Kudo T; Sato T; Hara T; Hosoi K; Usami M; Yoshida M; Takeuchi I; Nakase H; Iwama I; Arai K; Shimizu T
    J Gastroenterol; 2022 May; 57(5):344-356. PubMed ID: 35165800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urotensin II levels in patients with inflammatory bowel disease.
    Alicic D; Martinovic D; Rusic D; Zivkovic PM; Tadin Hadjina I; Vilovic M; Kumric M; Tokic D; Supe-Domic D; Lupi-Ferandin S; Bozic J
    World J Gastroenterol; 2021 Sep; 27(36):6142-6153. PubMed ID: 34629825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
    Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
    Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of neutrophil-to-lymphocyte ratio determined at initial diagnosis in predicting disease stage and discriminating between active and stable disease in patients with sarcoidosis: a cross-sectional study.
    Alparslan Bekir S; Sonkaya E; Ozbaki F; Aydogan Eroglu S; Sertcelik L; Duman D; Kavas M; Agca M; Erdem I; Ozmen I; Boga S; Hazar A; Sevim T; Turker H; Tuncay E; Gungor S; Karakurt Z
    Postgrad Med; 2022 Aug; 134(6):603-608. PubMed ID: 35619233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.